Literature DB >> 12430141

Androgen-mediated resistance to apoptosis.

Ronan N T Coffey1, R William G Watson, Amanda J O'Neill, Kevin Mc Eleny, John M Fitzpatrick.   

Abstract

BACKGROUND: Previous studies demonstrate that androgen is capable of exerting a protective effect in the androgen-sensitive human prostate cancer cell line LNCaP. Limited studies, however, have addressed the underlying mechanisms involved, in particular the effects of androgen on both pro- and anti-apoptotic gene expression.
METHODS: We investigated the effects of androgen on apoptotic sensitivity and the expression of the caspases and specific members of the Bcl-2 family in the LNCaP cell line. The effects of androgen on NF-kappaB activation were also investigated by using a gel mobility shift assay.
RESULTS: 5alpha-Dihydrotestosterone (5-alphaDHT) conferred resistance to radiation (5 Gy) and etoposide-induced apoptosis in the LNCaP cell line. This finding was associated with a time-dependent decrease in the expression of the caspases and pro-apoptotic Bcl-2 family members. 5-alphaDHT did not confer protection against apoptosis in the LNCaP line transfected with the IkappaB super repressor of NF-kappaB, nor in the androgen insensitive PC-3 and DU-145 cell lines.
CONCLUSION: The ability of 5-alphaDHT to raise the apoptotic threshold in the LNCaP cell line by altering specific pro-apoptotic gene expression suggests that androgen may serve as a general survival signal against diverse pathways that ultimately signal for apoptosis. We hypothesize that NF-kappaB serves as an important mediator in androgen survival signaling. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430141     DOI: 10.1002/pros.10159

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

1.  Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.

Authors:  Oskar W Rokhlin; Agshin F Taghiyev; Natalya V Guseva; Rebecca A Glover; Peter M Chumakov; Julia E Kravchenko; Michael B Cohen
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

2.  Relationship between ganglioside expression and anti-cancer effects of the monoclonal antibody against epithelial cell adhesion molecule in colon cancer.

Authors:  Dong Hoon Kwak; Jae-Sung Ryu; Chang-Hyun Kim; Kisung Ko; Jin Yeul Ma; Kyung-A Hwang; Young-Kug Choo
Journal:  Exp Mol Med       Date:  2011-12-31       Impact factor: 8.718

Review 3.  Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.

Authors:  Shaun McKenzie; Natasha Kyprianou
Journal:  J Cell Biochem       Date:  2006-01-01       Impact factor: 4.429

4.  The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.

Authors:  Shen Gao; Peng Lee; Hua Wang; William Gerald; Michael Adler; Liying Zhang; Yun-Fang Wang; Zhengxin Wang
Journal:  Mol Endocrinol       Date:  2005-02-24

Review 5.  Targeting anoikis resistance in prostate cancer metastasis.

Authors:  Shinichi Sakamoto; Natasha Kyprianou
Journal:  Mol Aspects Med       Date:  2010-02-11

6.  Association of HSP70-hom genetic variant with prostate cancer risk.

Authors:  Sana Sfar; Hamadi Saad; Faouzi Mosbah; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2007-06-20       Impact factor: 2.316

7.  Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.

Authors:  Boris Risek; Piotr Bilski; Annette B Rice; William T Schrader
Journal:  Mol Endocrinol       Date:  2008-06-18

8.  Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo.

Authors:  Konstantin Golovine; Peter Makhov; Robert G Uzzo; Tavis Shaw; David Kunkle; Vladimir M Kolenko
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

9.  Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells.

Authors:  Liang Wang; Cheng-Lung Hsu; Jing Ni; Peng-Hui Wang; Shuyuan Yeh; Peter Keng; Chawnshang Chang
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7.

Authors:  Soyoung Kim; Bang Yeon Hwang; Bao-Ning Su; Heebyung Chai; Qiuwen Mi; A Douglas Kinghorn; Robert Wild; Steven M Swanson
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.